Next, we examined whether these two aptamers could neutralize infection from live SARS‐CoV‐2 virus in a Biological Safety Level‐3 (BSL‐3) laboratory, considering that their binding to RBD might interrupt the interaction of spike protein with the human Angiotensin‐Converting Enzyme II (hACE2) receptor (Figure 4A). The gene discussed is CHMP5; the disease is infection.